Search Clinical Trials
608,149 trials
ID
Status
Phase
Title
Sponsor
NCT07891000
Effects of Different Amounts of Plyometric Exercise Without Jumping in Physically Inactive Older AdultsUniversity of Americas - ChiliNot Yet RecruitingNot Applicable
NCT07891000Not Yet Recruiting
Not Applicable
Effects of Different Amounts of Plyometric Exercise Without Jumping in Physicall...University of Americas -...
NCT07892664
Reducing Arterial Inflammation Using Eplerenone and Statins in HIVMassachusetts General HospitalNot Yet RecruitingPhase 2
NCT07892664Not Yet Recruiting
Phase 2
Reducing Arterial Inflammation Using Eplerenone and Statins in HIVMassachusetts General Hos...
NCT07891065
EEG As a Genetic Selection Lever in Autism Spectrum DisorderCentre Hospitalier Régional Metz-ThionvilleNot Yet Recruiting
NCT07891065Not Yet Recruiting
—
EEG As a Genetic Selection Lever in Autism Spectrum DisorderCentre Hospitalier Région...
NCT07891741
Study of 3D Ultrasound for Support of Hemodialysis CannulationNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingNot Applicable
NCT07891741Recruiting
Not Applicable
Study of 3D Ultrasound for Support of Hemodialysis CannulationNational Institute of Dia...
NCT07892339
Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis: A Prospective Randomized Controlled Study.Cairo UniversityNot Yet RecruitingPhase 3
NCT07892339Not Yet Recruiting
Phase 3
Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treat...Cairo University
NCT07893184
Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardiac Surgery Via SternotomyMaastricht University Medical CenterEnrolling By InvitationNot Applicable
NCT07893184Enrolling By Invitation
Not Applicable
Feasibility of Physical Prehabilitation for High-Risk Patients Undergoing Cardia...Maastricht University Med...
NCT07890948
NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS WITH IRRITABLE BOWEL SYNDROME: A RANDOMIZED, SINGLE-BLIND, SHAM-CONTROLLED CROSSOVER STUDYHoag Memorial Hospital PresbyterianNot Yet RecruitingNot Applicable
NCT07890948Not Yet Recruiting
Not Applicable
NEUROMODULATION WITH TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN ADULTS...Hoag Memorial Hospital Pr...
NCT07893314
Effects of Food Intake on Biomarker Activity in Normal Humans Taking ImmulinaUniversity of Mississippi Medical CenterNot Yet RecruitingPhase 2
NCT07893314Not Yet Recruiting
Phase 2
Effects of Food Intake on Biomarker Activity in Normal Humans Taking ImmulinaUniversity of Mississippi...
NCT07893353
Mechanisms and Intervention Strategies of Perioperative Glycemic Variability on Postoperative DeliriumFujian Medical University Union HospitalRecruitingNot Applicable
NCT07893353Recruiting
Not Applicable
Mechanisms and Intervention Strategies of Perioperative Glycemic Variability on...Fujian Medical University...
NCT07891078
Functional Benefits of Multisite Upper Limb Surgery in Children With Unilateral Cerebral Palsy (RETRO-CHIRc)Centre Médico-Chirurgical de Réadaptation des Massues Croix Rouge FrançaiseRecruiting
NCT07891078Recruiting
—
Functional Benefits of Multisite Upper Limb Surgery in Children With Unilateral...Centre Médico-Chirurgical...
NCT07892027
Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma Receiving CAR T-Cell TherapyUniversity of Michigan Rogel Cancer CenterRecruitingPhase 2
NCT07892027Recruiting
Phase 2
Natalizumab for the Prevention of ICANS in Patients With Recurrent or Refractory...University of Michigan Ro...
NCT07891650
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Related to Cerebral Small Vessel DiseaseMinistry of Science and Technology of the People´s Republic of ChinaNot Yet RecruitingNot Applicable
NCT07891650Not Yet Recruiting
Not Applicable
Personalized Intermittent Theta Burst Stimulation for Cognitive Impairment Relat...Ministry of Science and T...
NCT07891923
Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Multiple MyelomaIndian Council of Medical ResearchRecruitingPhase 2
NCT07891923Recruiting
Phase 2
Less Doses of Daratumumab Are Adequate to Achieve Response in Newly Diagnosed Mu...Indian Council of Medical...
NCT07892534
Telenursing-Based Sleep Coaching for Adults Living With HIV With Insomnia SymptomsIndonesian Endowment Fund for Education (LPDP)Not Yet RecruitingNot Applicable
NCT07892534Not Yet Recruiting
Not Applicable
Telenursing-Based Sleep Coaching for Adults Living With HIV With Insomnia Sympto...Indonesian Endowment Fund...
NCT07892053
Prehospital Response and Emergency Stroke Transport OptimisationBeijing Tiantan HospitalNot Yet RecruitingNot Applicable
NCT07892053Not Yet Recruiting
Not Applicable
Prehospital Response and Emergency Stroke Transport OptimisationBeijing Tiantan Hospital
NCT07891286
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Children, Adolescents and Young AdultsNational Cancer Institute (NCI)Not Yet RecruitingPhase 2
NCT07891286Not Yet Recruiting
Phase 2
Mirdametinib to Reduce the Size of Large/Giant Congenital Melanocytic Nevi in Ch...National Cancer Institute...
NCT07893301
The Impact of Postbiotic Supplementation on Tolerability and Physiological/Metabolic ParametersFederico II UniversityActive Not RecruitingNot Applicable
NCT07893301Active Not Recruiting
Not Applicable
The Impact of Postbiotic Supplementation on Tolerability and Physiological/Metab...Federico II University
NCT07892950
Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Injection in the Treatment of Acute Respiratory Distress SyndromeGuangZhou Cellgenes Biotechnology Co., Ltd.CompletedPhase 1
NCT07892950Completed
Phase 1
Clinical Trial of CG-BM1 Allogeneic Human Bone Marrow Mesenchymal Stem Cell Inje...GuangZhou Cellgenes Biote...
Result Breakdown
Not yet recruiting12 (60%)
Recruiting5 (25%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
Completed1 (5%)
not_applicable9 (45%)
Phase 26 (30%)
Not Specified3 (15%)
Phase 31 (5%)
Phase 11 (5%)